1. Home
  2. XELB vs INM Comparison

XELB vs INM Comparison

Compare XELB & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

N/A

Current Price

$0.33

Market Cap

8.4M

Sector

Miscellaneous

ML Signal

N/A

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

SELL

Current Price

$15.56

Market Cap

8.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
XELB
INM
Founded
2011
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
8.8M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
XELB
INM
Price
$0.33
$15.56
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $4.00
N/A
AVG Volume (30 Days)
★ 628.8K
69.4K
Earning Date
11-16-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
48.37
★ 62.68
EPS
N/A
★ N/A
Revenue
N/A
★ $4,942,633.00
Revenue This Year
$30.13
N/A
Revenue Next Year
$99.55
$26.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 7.50
52 Week Low
$0.27
$0.58
52 Week High
$2.47
$16.44

Technical Indicators

Market Signals
Indicator
XELB
INM
Relative Strength Index (RSI) 36.51 99.25
Support Level $0.29 $1.00
Resistance Level $0.58 N/A
Average True Range (ATR) 0.09 0.50
MACD 0.02 1.26
Stochastic Oscillator 16.79 86.67

Price Performance

Historical Comparison
XELB
INM

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

Share on Social Networks: